Logo image of PETS

PETMED EXPRESS INC (PETS) Stock Price, Forecast & Analysis

USA - NASDAQ:PETS - US7163821066 - Common Stock

1.68 USD
-0.18 (-9.68%)
Last: 11/19/2025, 2:57:16 PM

PETS Key Statistics, Chart & Performance

Key Statistics
Market Cap35.31M
Revenue(TTM)226.97M
Net Income(TTM)-6.27M
Shares21.02M
Float14.54M
52 Week High6.85
52 Week Low1.6
Yearly Dividend0.01
Dividend YieldN/A
EPS(TTM)-0.3
PEN/A
Fwd PEN/A
Earnings (Next)02-09 2026-02-09
IPO2000-04-06
Sector
GICS IndustrySpecialty Retail
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS SubIndustryOther Specialty Retail


PETS short term performance overview.The bars show the price performance of PETS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

PETS long term performance overview.The bars show the price performance of PETS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PETS is 1.68 USD. In the past month the price decreased by -42.07%. In the past year, price decreased by -64.85%.

PETMED EXPRESS INC / PETS Daily stock chart

PETS Latest News, Press Relases and Analysis

PETS Competitors/Peers

The largest stocks on the US markets in the "Other Specialty Retail" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TSCO TRACTOR SUPPLY COMPANY 25.19 27.77B
ULTA ULTA BEAUTY INC 18.95 22.19B
DKS DICK'S SPORTING GOODS INC 15.03 18.86B
CHWY CHEWY INC - CLASS A 94.43 14.10B
FIVE FIVE BELOW 26.37 8.10B
BBWI BATH & BODY WORKS INC 6.14 4.36B
ASO ACADEMY SPORTS & OUTDOORS IN 7.44 2.79B
WRBY WARBY PARKER INC-CLASS A 42.94 2.09B
EYE NATIONAL VISION HOLDINGS INC 40.84 1.97B
SBH SALLY BEAUTY HOLDINGS INC 7.34 1.39B
WINA WINMARK CORP 35.89 1.43B
UPBD UPBOUND GROUP INC 3.84 926.69M

About PETS

Company Profile

PETS logo image PetMed Express, Inc. provides markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 173 full-time employees. The company went IPO on 2000-04-06. The firm is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. The company markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The firm offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Company Info

PETMED EXPRESS INC

420 South Congress Avenue

Delray Beach FLORIDA 33445 US

CEO: Menderes Akdag

Employees: 173

PETS Company Website

PETS Investor Relations

Phone: 15614264444

PETMED EXPRESS INC / PETS FAQ

What does PETMED EXPRESS INC do?

PetMed Express, Inc. provides markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 173 full-time employees. The company went IPO on 2000-04-06. The firm is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. The company markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The firm offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.


What is the stock price of PETMED EXPRESS INC today?

The current stock price of PETS is 1.68 USD. The price decreased by -9.68% in the last trading session.


Does PETS stock pay dividends?

PETS does not pay a dividend.


How is the ChartMill rating for PETMED EXPRESS INC?

PETS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the market capitalization of PETS stock?

PETMED EXPRESS INC (PETS) has a market capitalization of 35.31M USD. This makes PETS a Nano Cap stock.


Can you provide the upcoming earnings date for PETMED EXPRESS INC?

PETMED EXPRESS INC (PETS) will report earnings on 2026-02-09.


What is the outstanding short interest for PETMED EXPRESS INC?

The outstanding short interest for PETMED EXPRESS INC (PETS) is 11.44% of its float.


PETS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PETS Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PETS. The financial health of PETS is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PETS Financial Highlights

Over the last trailing twelve months PETS reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS increased by 22% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -4.22%
ROE -7.37%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-125.68%
Sales Q2Q%-30.13%
EPS 1Y (TTM)22%
Revenue 1Y (TTM)-19.24%

PETS Forecast & Estimates

6 analysts have analysed PETS and the average price target is 2.81 USD. This implies a price increase of 66.96% is expected in the next year compared to the current price of 1.68.

For the next year, analysts expect an EPS growth of 26.23% and a revenue growth -14.05% for PETS


Analysts
Analysts40
Price Target2.81 (67.26%)
EPS Next Y26.23%
Revenue Next Year-14.05%

PETS Ownership

Ownership
Inst Owners38.7%
Ins Owners6.24%
Short Float %11.44%
Short Ratio12.22